Approval · Notice of Compliance 381 · 2002
COREG: Notice of Compliance 381
Issued April 10, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 381
- Date
- April 10, 2002
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- New indication: treatment of severe heart failure
- Therapeutic class
- Congestive heart failure agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COREG | Not yet assigned | — |
Medicinal ingredients
- CARVEDILOL 3.125 MG per TAB
- CARVEDILOL 6.25 MG per TAB
- CARVEDILOL 12.5 MG per TAB
- CARVEDILOL 25 MG per TAB